Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

Hilleman Laboratories

Tracked across 1 events · 543 articles · First seen Mar 09, 2018 · Last active Sep 16, 2026

Sentiment
20
Attention
8
Events
1
Relationships
12
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
8 20
Accidents
Impact: Developing a promising rVSV-based Bundibugyo vaccine, with WHO calling it the 'most promising' candidate. Its progress could provide a key tool against the outbreak.
Mar 09, 2018 · 543 articles
Coalition for Epidemic Preparedness Innovations grantee ↔ Hilleman Laboratories Hilleman Laboratories is a key grantee and development partner of Coalition for
Coalition for Epidemic Preparedness Innovations funder ↔ Hilleman Laboratories Coalition for Epidemic Preparedness Innovations (CEPI) provides significant gran
Democratic Republic of the Congo ↔ Hilleman Laboratories
Democratic Republic of the Congo ↔ Hilleman Laboratories
AstraZeneca ↔ Hilleman Laboratories
AstraZeneca ↔ Hilleman Laboratories
Uganda ↔ Hilleman Laboratories
Uganda ↔ Hilleman Laboratories
World Health Organization ↔ Hilleman Laboratories
World Health Organization ↔ Hilleman Laboratories
Canada ↔ Hilleman Laboratories
Canada ↔ Hilleman Laboratories
ERGEN INTELLIGENCE
Track Hilleman Laboratories live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.